It has also been shown that an elevated serum level of FABP4 is associated with obesity, insulin resistance, hypertension, cardiac dysfunction, atherosclerosis and cardiovascular events [9, 16–23]. Here, FABP4 is linked to obesity due to melanocortin 4 receptor deficiency.